Navigation Links
Absorption Pharmaceuticals Expands Sales and Service Team to Answer Physicians' Growing Demand for Promescent
Date:11/21/2013

LOS ANGELES, Nov. 21, 2013 /PRNewswire/ -- Absorption Pharmaceuticals (AP), the innovators behind Promescent, announced today the addition of three new experts to their national sales and support team to better cater to its growing demand from urologists and pharmacies. Word of Promescent's superior efficacy, minimal side effects, ease-of-use, and low cost per dose for treating premature ejaculation is spreading fast, so in an effort to solidify continued success and satisfaction, the company has recruited some of the most knowledgeable and qualified salespersons in the field to join their team. 

"Only 9% of men with PE seek help from their physician, so there's a lack of knowledge among patients and many urologists with the causes and latest treatment options for PE," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "It's critical that our sales and service team have the experience in sexual medicine to efficiently educate physicians, PAs, and pharmacists."

Lisa Waddington joins AP as the director of Eastern U.S. regional sales, based in New York City.  She comes to AP from Bryce Rx Laboratories, one of the nation's compounding-only pharmacies, which specialized in erectile dysfunction. Lisa developed Bryce Rx's distribution of advanced ED medications, including Trimix, with hundreds of urologists across the United States.

Victoria Skrip joins AP as the director of Midwest U.S. regional sales, based in Chicago. Prior to AP, she was an award-winning urology and women's health care representative for Warner Chilcott Pharmaceuticals, based in Louisville, Kentucky.

Mary Ann Adkins joins AP as the director of physician services, based in Las Vegas. Mary Ann has extensive experience in sexual medicine, particularly with solutions following radical prostatectomy to help men regain sexual function.  She understands the physician, PA, and administrative staff goals for patient care and will bring that perspective to AP.

"I'm excited to add Lisa, Victoria and Mary Ann to the team," concludes Abraham. "Not only do they provide additional geographic coverage, but each of them provides new knowledge in the field of sexual medicine that strengthens the company's ability to serve both patient and physician."

Already, there are more than one thousand urologists across the U.S. currently using Promescent as first-line treatment for premature ejaculation, and its popularity is now also surging among sex therapists and even general practitioners.  With three sterling new additions to their sales force, Absorption Pharmaceuticals can now extend their aid and reach even further.

About Absorption Pharmaceuticals
Absorption Pharmaceuticals is the maker of Promescent, an FDA-approved, topical medication for premature ejaculation. Many key opinion leaders in sexual medicine consider Promescent the leading solution for premature ejaculation in the U.S. The California-based company has been featured in numerous media including CNBC, NBC News, Dr. Oz, the Doctors, CNN and the National Post. Learn more at www.promescent.com.

For more information, or to purchase Promescent, please visit https://www.promescent.com/.


'/>"/>
SOURCE Absorption Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
2. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
3. Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd
4. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
5. Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
6. Absorption Systems Registers with FDA as a Generic Drug Facility under GDUFA
7. Absorption Systems announces novel test platform for interactions with the BCRP transporter
8. Actinium Pharmaceuticals To Present At The LD Micro Conference
9. Acquisitions, Conference Participations, Court Rulings, and Product Deliveries - Research Report on Zoetis, Aegerion Pharmaceuticals, Edwards, Community Health Systems, and Air Methods
10. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
11. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 ... Surgical drainage devices are tubes used to remove excess ... include, blood, serum, pus, urine, bile or lymph. Surgical ... types of surgery such as orthopedics surgery, cardiovascular surgery, ... device is prophylactic post-surgery to prevent accumulation of fluid ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... and HR decision-makers are preparing for how his administration could impact the employee ... insight into what changes are most likely to make it through Congress. His ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the ... dispensaries and head shops –can’t help but be heartened by the industry’s current surge. ... odor aptly described as “skunk smell.” At last they can simply, safely and ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... There is ... Regional Hospital, according to a special report in the May issue of Consumer Reports ... its highest quality ranking for results achieved during and after coronary bypass and aortic ...
(Date:4/24/2017)... ... 2017 , ... LG CNS Healthcare Solutions debuted the next ... Telehealth 2.0, the American Telemedicine Association’s national conference. , BYOD has been added ... pre-programmed tablet in a remarkably easy-to-use kit for patients. “BYOD is the next ...
Breaking Medicine News(10 mins):